Dr. Iffath Abbasi Hoskins Joins Americord's Advisory Board

NEW YORK, July 15, 2014 /PRNewswire/ -- Americord announced today that Iffath Abbasi Hoskins, M.D. has joined the company's Advisory Board. Dr. Hoskins is a Clinical Associate Professor in the Department of Obstetrics and Gynecology at NYU Langone Medical Center in New York City. She is a practicing obstetrician-gynecologist and a sub-specialist in maternal-fetal medicine, which focuses on high-risk and complicated pregnancies.

"We are so pleased that Dr. Hoskins has agreed to join Americord's Advisory Board," said Americord CEO Martin Smithmyer. "She brings a wealth of experience in pregnancy and childbirth that is valuable to us as we pursue innovative technologies in the field of cord blood banking." Americord's Executive Medical Director, Dr. Robert Dracker, a highly regarded stem cell banking leader, and Dr. Eric Adler, a specialist in cardiovascular medicine who has done extensive research in the field of stem cells, are also members of the Advisory Board.

Dr. Hoskins and her colleagues are currently involved in investigations in areas pertaining to maternal and fetal well being, including antepartum fetal heart rate testing, fetal ultrasonography, maternal screening, obstetrical surgical techniques, maternal acid base status, and obstetrical complications including placenta previa. She is also involved in an ongoing investigation in the area of the pathogenesis and diagnosis of chorioamnionitis. Specifically, studying leukocyte and other esterases' activity for the diagnosis of this infection, the long-term goal being to develop a rapid simple, reliable assay for detecting chorioamnionitis in pregnancy and labor.

Dr. Hoskins has co-authored numerous scientific articles on pregnancy and childbirth for various medical publications. Dr. Hoskins earned her medical degree from Dow Medical College in Pakistan.

About Americord Registry

Americord is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company's laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. You may visit Americord's website at cordadvantage.com for more information. You may also find Americord on Facebook and follow the company on Twitter.

SOURCE Americord Registry